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The resistance to antimicrobial agents brings a need of novel antimicrobial agents. We have synthesized and found the in vitro
antibacterial activity of salicylanilide esters with benzoic acid (2-(phenylcarbamoyl)phenyl benzoates) in micromolar range.
They were evaluated in vitro for the activity against eight fungal and eight bacterial species. All derivatives showed a signiﬁcant
antibacterial activity against Gram-positive strains with minimum inhibitory concentrations ≥0.98μmol/L including methicillin-
resistant Staphylococcus aureus strain. The most active compounds were 5-chloro-2-(3,4-dichlorophenylcarbamoyl)phenyl
benzoate and 4-chloro-2-(4-(triﬂuoromethyl)phenylcarbamoyl)phenyl benzoate. The antifungal activity is signiﬁcantly lower.
1.Introduction
The worldwide epidemic of antibiotic resistance is in danger
of ending the “golden age” of antibiotic therapy and
therefore is touching all people [1]. Major current prob-
lems arise from the spread of nosocomial antibiotic-
resistant bacteria such as methicillin-resistant Staphylococcus
aureus (MRSA), extended-spectrum β-lactamases-produc-
ing (ESBL) Escherichia coli or Klebsiella spp., multiresistant
Pseudomonas, or Acinetobacter s p .a sw e l la sClostridium
diﬃcile [2].
The situation in the fungal kingdom is a bit diﬀerent.
Over the past decades there has been a growing number of
immunocompromised patients (e.g., patients with AIDS or
after transplantations) who can develop opportunistic
mycoses caused by expanding spectrum of fungal pathogens,
including those with problematic susceptibility to current
antifungal drugs. Pathogenic fungi can use diﬀerent mech-
anisms of resistance to diverse drugs with unrelated modes
of action [3].
The searching for potential antimicrobial agents is still
challenging and new groups of compounds are desired [4].
Various salicylanilide (2-hydroxy-N-phenylbenzamide)
esters have displayed good antibacterial and antifungal activ-
ities, especially against Gram-positive strains [5–7]. Recently
salicylanilides were described besides an excellent antibac-
terial acting against both drug-sensitive and methicillin-
resistant S. aureus inhibition activity towards bacterial trans-
glycosylase,anenzymenecessaryfortheformationofthecell
wall [8].
Benzoic acid alone is known as a nonspeciﬁc antimi-
crobial agent with the wide spectrum of the activities
against human pathogenic fungi and bacteria with diﬀerent
minimum inhibitory concentration (MIC) values [9–14];
moreoveritwasbeingevaluatedasaninhibitorofβ-carbonic
anhydrase, a new molecular target occurring in C. albicans
and Cryptococcus neoformans [15]. The review of the benzoic
acid as preservative agent, the mechanisms of action, and
resistance were published [16].2 The Scientiﬁc World Journal
Based on these facts, we designed and evaluated new sali-
cylanilide benzoates as potential antibacterial and antifungal
agents.
2.MaterialandMethods
2.1. Chemistry. Salicylanilides were prepared by the pro-
cedure described previously [7]. The esters were prepared
from salicylanilides by using benzoic acid and N,N  -di-
cyclohexylcarbodiimide as dehydrating and condensation
agent (e.g., [7]). The general structure is presented in the
head of Table 1.
All used chemicals were purchased from commercial
sources (Sigma-Aldrich) and they were used without a
further puriﬁcation. Reactions were monitored by thin-layer
chromatography plates coated with 0.2mm silica gel 60 F254
(Merck) visualized by UV irradiation (254nm). All syn-
thesized compounds were characterized. Elemental analysis
( C ,H ,N )w a sp e r f o r m e do na na u t o m a t i cm i c r o a n a l y s e r
CHNS-O CE instrument (FISONS EA 1110, Italy). Melting
points were determined on a Melting Point machine B-
540 (B¨ uchi) apparatus using open capillaries and they are
uncorrected. Infrared spectra (ATR) were recorded on FT-
IR spectrometer Nicolet 6700 FT-IR in the range of 400–
4000cm−1. The NMR spectra were recorded on a Varian
VNMR S500 (500MHz for 1H and 125MHz for 13C;
Varian, Inc., Palo Alto, USA) at ambient temperature using
deuterated dimethyl sulfoxide (DMSO-d6) solutions of the
samples. The chemical shifts δ are given in ppm, with respect
to tetramethylsilane as an internal standard. The coupling
constants (J) are reported in Hz.
2.2. Biology
2.2.1. Antibacterial Evaluation. The in vitro antibacterial
activity was assayed against next Gram-positive and Gram-
negative strains: Staphylococcus aureus CCM 4516/08, meth-
icillin-resistant Staphylococcus aureus H 5996/08 (MRSA),
Staphylococcus epidermidis H 6966/08, Enterococcus sp. J
14365/08, Escherichia coli CCM4517, Klebsiella pneumoniae
D11750/08,ESBL-positiveKlebsiellapneumoniaeJ14368/08,
and Pseudomonas aeruginosa CCM 1961.
The microdilution broth method modiﬁed according to
standard M07-A07 [17] in Mueller-Hinton broth (HiMedia
Laboratories, India) was adjusted to pH 7.4 (±0.2). The
investigated compounds were dissolved in DMSO to the
ﬁnal concentrations ranging from 500 to 0.49μmol/L. Peni-
cillin G (benzylpenicillin) and benzoic acid were used as
comparative standard drugs. Bacterial inoculum in sterile
water was prepared to match 0.5 McFarland scale (1.5 ×
108 CFU/mL). The minimum inhibitory concentrations
(MICs) were assayed as 80% (IC80)o rh i g h e rr e d u c t i o no f
growth in comparison to the control. The determination of
results was performed visually and spectrophotometrically
( a t5 4 0n m ) .T h ev a l u e so fM I C sw e r ed e t e r m i n e da f t e r2 4
and 48h of incubation in the darkness at 35◦C( ±0.1) in a
humid atmosphere.
2.2.2. Antifungal Evaluation. The inhibitory activity was
determined in vitro against four yeast strains (Candida
albicans ATCC 44859, Candida tropicalis 156, Candida krusei
E28, and Candida glabrata 20/I) and four moulds (Tri-
chosporon asahii 1188, Aspergillus fumigatus 231, Absidia
corymbifera 272, and Trichophyton mentagrophytes 445).
The method used was microdilution broth method in
the format of the CLSI M27-A3 and M38 A2 guidelines
for yeasts and moulds [18, 19] in RPMI 1640 with glu-
tamine (KlinLab, the Czech Republic) buﬀered to pH 7.0
with 0.165M of 3-morpholino-propane-1-sulphonic acid
(Sigma-Aldrich, Germany). DMSO served as a diluent for all
compounds. Fungal inoculum was prepared to give a ﬁnal
concentration of 5 × 103± 0.2CFU/mL. Fluconazole was
used as a reference drug. Other conditions were the same as
for antibacterial assay; only for T. mentagrophytes the ﬁnal
MICweredeterminedafter72and120hofincubation.MICs
were determined twice and in duplicate.
3. Results and Discussion
3.1. Chemistry. Eighteen new salicylanilide benzoates were
synthesized. The yields ranged from 44 to 88%.
4-Chloro-2-(3-chlorophenylcarbamoyl)phenyl Benzoate (1).
White solid; yield 82%; mp 146.5–149◦C. IR (ATR): 3325
(NH amide; m), 3081, 2932, 2853, 1716 (CO ester; s), 1672
(CO amide; s), 1590, 1525, 1483, 1451, 1424, 1309, 1286,
1267, 1251, 1208, 1181, 1104, 1085, 1067, 1023, 902, 873,
786, 735, 703, 681. 1H NMR (500MHz, DMSO): δ 10.69
( 1 H ,b s ,N H ) ,8 . 0 7( 2 H ,d ,J = 7.5Hz, H2  ,H 6   ), 7.83 (1H,
d, J = 2.5Hz, H3), 7.76–7.69 (3H, m, H5, H6, H2 ), 7.56
(1H, t, J = 7.7Hz, H4  ), 7.53–7.49 (3H, m, H6 ,H 3   ,H 5   ),
7.31 (1H, t, J = 8.1Hz, H5 ), 7.11 (1H, dd, J = 1.9Hz, J =
7.9Hz, H4 ). 13C NMR (125MHz, DMSO): δ 164.3, 163.0,
147.0, 140.3, 134.4, 133.1, 131.8, 131.2, 130.6, 130.4, 130.0,
129.1, 128.6, 128.0, 125.7, 123.8, 119.4, 118.4. Anal. Calcd.
for C20H13Cl2NO3 (386.23): C, 62.19; H, 3.39; N, 3.63.
Found: C, 61.89; H, 3.50; N, 3.87.
5-Chloro-2-(3-chlorophenylcarbamoyl)phenyl Benzoate (2).
White solid; yield 68%; mp 166–168◦C. IR (ATR): 3282 (NH
amide; m), 3072, 1739 (CO ester; s), 1647 (CO amide; s),
1600, 1589, 1548, 1481, 1450, 1410, 1320, 1255, 1241, 1192,
1075, 1051, 1021, 915, 896, 873, 854, 829, 782, 702, 676, 660.
1H NMR (500MHz, DMSO): δ 10.65 (1H, bs, NH), 8.08
(2H, d, J = 7.9Hz, H2  ,H 6   ), 7.79 (1H, d, J = 8.3Hz, H3),
7.76–7.67 (3H, m, H4, H6, H2 ), 7.58–7.48 (4H, m, H6 ,
H3  ,H 4   ,H 5   )7 . 3 0( 1 H ,t ,J = 8.1Hz, H5 ), 7.10 (1H, dd,
J = 1.8Hz, J = 7.9Hz, H4 ). 13C NMR (125MHz, DMSO):
δ 164.2, 163.5, 148.9, 140.3, 135.8, 134.4, 133.1, 131.0, 130.6,
130.1, 129.1, 128.6, 128.5, 126.5, 124.0, 123.7, 119.4, 118.4.
Anal. Calcd. for C20H13Cl2NO3 (386.23): C, 62.19; H, 3.39;
N, 3.63. Found: C, 62.34; H, 3.22; N, 3.79.
4-Chloro-2-(4-chlorophenylcarbamoyl)phenyl Benzoate (3).
White solid; yield 80%; mp 185–187◦C. IR (ATR): 3309 (NH
amide; m), 3072, 2928, 2850, 1741 (CO ester; s), 1649 (COThe Scientiﬁc World Journal 3
Table 1: Antibacterial activity of benzoates 1-18.
O
O
O
R1
R2
N
H
MIC/IC80 [μmol/L]
R1 R2 Staphylococcus aureus MRSA S. aureus Staphylococcus epidermidis Enterococcus sp. Pseudomonas aeruginosa
24h 48h 24h 48h 24h 48h 24h 48h 24h 48h
(1) 4-Cl 3-Cl 0.98 3.9 0.98 3.9 1.95 7.81 31.25 62.5 3.9 7.81
(2) 5-Cl 3-Cl 3.9 3.9 3.9 3.9 3.9 62.5 >125 >125 >125 >125
(3) 4-Cl 4-Cl 3.9 3.9 3.9 3.9 >125 >125 >125 >125 >125 >125
(4) 5-Cl 4-Cl 15.62 31.25 15.62 31.25 31.25 31.25 >125 >125 >125 >125
(5) 4-Cl 3,4-diCl 1.95 3.9 1.95 7.81 1.95 1.95 1.95 1.95 >125 >125
(6) 5-Cl 3,4-diCl 1.95 1.95 1.95 1.95 1.95 1.95 1.95 1.95 >125 >125
(7) 4-Cl 3-Br 3.9 7.81 3.9 7.81 1.95 3.9 7.81 >125 >125 >125
(8) 5-Cl 3-Br 1.95 3.9 3.9 7.81 1.95 3.9 7.81 >125 >125 >125
(9) 4-Cl 4-Br 1.95 7.81 7.81 15.62 3.9 15.62 125 >125 >125 >125
(10) 5-Cl 4-Br 62.5 >125 125 >125 15.62 >125 >125 >125 >125 >125
(11) 4-Cl 3-F 3.9 7.81 3.9 7.81 1.95 7.81 31.25 >125 >125 >125
(12) 5-Cl 3-F 3.9 7.81 3.9 15.62 1.95 7.81 7.81 >125 >125 >125
(13) 4-Cl 4-F 7.81 7.81 15.62 15.62 1.95 3.9 62.5 >125 >125 >125
(14) 5-Cl 4-F 3.9 7.81 7.81 15.62 1.95 3.9 >125 >125 >125 >125
(15) 4-Cl 4-CF3 1.95 1.95 1.95 1.95 1.95 1.95 1.95 1.95 >125 >125
(16) 5-Cl 4-CF3 3.9 3.9 3.9 3.9 3.9 3.9 >125 >125 >125 >125
(17) 4-Cl 3-CF3 1.95 3.9 1.95 7.81 1.95 3.9 7.81 >125 >125 >125
(18) 4-Br 4-CF3 1.95 1.95 1.95 1.95 1.95 1.95 1.95 >125 >125 >125
PNC — — 0.98 0.98 62.5 125 250 250 7.81 15.62 >500 >500
BA — — >500 >500 >500 >500 >500 >500 >500 >500 >500 >500
PNC: penicillin G; BA: benzoic acid. The lowest MIC value(s) for each strain are bolded.
amide; s), 1593, 1543, 1537, 1490, 1451, 1405, 1314, 1257,
1245,1197,1099,1053,1023,875,836,814,724,706,669. 1H
NMR (500MHz, DMSO): δ 10.65 (1H, bs, NH), 8.06 (2H, d,
J = 7.2Hz, H2  ,H 6   ), 7.82 (1H, d, J = 2.6Hz, H3), 7.73–
7.68 (2H, m, H5, H6), 7.63 (2H, d, J = 8.9Hz, H2 ,H 6  ),
7.55 (1H, t, J = 7.8Hz, H4  ), 7.50 (2H, t, J = 8.7Hz,
H3  ,H 5   ), 7.33 (2H, d, J = 8.9Hz, H3 ,H 5  ). 13CN M R
(125MHz,DMSO):δ 164.3,162.8,146.9,137.8,134.3,131.6,
131.3, 130.4, 130.0, 129.1, 128.7, 128.0, 127.7, 127.1, 125.7,
121.5. Anal. Calcd. for C20H13Cl2NO3 (386.23): C, 62.19; H,
3.39; N, 3.63. Found: C, 62.00; H, 3.45; N, 3.87.
5-Chloro-2-(4-chlorophenylcarbamoyl)phenyl Benzoate (4).
White solid; yield 81%; mp 192–194◦C. IR (ATR): 3344 (NH
amide; m), 3070, 1746 (CO ester; s), 1650 (CO amide; s),
1592, 1533, 1491, 1453, 1401, 1307, 1259, 1243, 1191,
1176, 1077, 1052, 1021, 915, 893, 827, 762, 703. 1HN M R
(500MHz, DMSO): δ 10.61 (1H, bs, NH), 8.07 (2H, d, J =
7.4Hz, H2  ,H 6   ), 7.78 (1H, d, J = 8.3Hz, H3), 7.73–7.67
( 2 H ,m ,H 4 ,H 6 ) ,7 . 6 3( 2 H ,d ,J = 8.8Hz, H2 ,H 6  ), 7.58–
7.53 (3H, m, H3  ,H 4   ,H 5   ), 7.32 (2H, d, J = 8.8Hz, H3 ,
H5 ). 13C NMR (125MHz, DMSO): δ 164.2, 163.3, 148.9,
137.9, 135.7, 134.4, 130.9, 130.1, 129.1, 128.8, 128.7, 128.6,4 The Scientiﬁc World Journal
127.6, 126.5, 123.9, 121.4. Anal. Calcd. for C20H13Cl2NO3
(386.23): C, 62.19; H, 3.39; N, 3.63. Found: C, 61.87; H, 3.54;
N, 3.90.
4-Chloro-2-(3,4-dichlorophenylcarbamoyl)phenyl Benzoate
(5). White solid; yield 52%; mp 169.5–172◦C. IR (ATR):
3304 (NH amide; m), 3074, 2928, 2850, 1713 (CO ester; s),
1668 (CO amide; s), 1578, 1516, 1478, 1469, 1449, 1384,
1298,1275,1247,1208,1101,1087,1066,1026,889,866,704.
1H NMR (500MHz, DMSO): δ 10.79 (1H, bs, NH), 8.06
(2H,d,J = 7.4Hz,H2  ,H6   ),7.92(1H,s,H2 ),7.84(1H,d,
J = 2.6Hz, H3), 7.74–7.69 (2H, m, H5, H6), 7.58–7.50 (5H,
m, H5 ,H 6  ,H 3   ,H 4   ,H 5   ). 13C NMR (125MHz,
DMSO): δ 164.3, 163.0, 147.0, 138.9, 134.4, 131.9, 131.1,
130.9, 130.4, 130.0, 129.1, 128.6, 128.0, 127.9, 127.0, 125.7,
121.1, 120.0. Anal. Calcd. for C20H12Cl3NO3 (420.67): C,
57.10; H, 2.88; N, 3.33. Found: C, 57.40; H, 2.99; N, 3.41.
5-Chloro-2-(3,4-dichlorophenylcarbamoyl)phenyl Benzoate
(6). White solid; yield 82%; mp 155–157◦C. IR (ATR): 3412
(NH amide; m), 3093, 2930, 2851, 1754 (CO ester; s), 1682
(CO amide; s), 1593, 1527, 1475, 1450, 1400, 1375, 1303,
1244, 1180, 1135, 1042, 1020, 914, 881, 823, 759, 700. 1H
NMR (500MHz, DMSO): δ 10.75 (1H, bs, NH), 8.07 (2H,
d, J = 7.9Hz, H2  ,H 6   ), 7.92 (1H, s, H2 ), 7.79 (1H, d, J =
8.3Hz, H3), 7.74–7.69 (2H, m, H4, H6), 7.59–7.53 (5H, m,
H5 ,H 6  ,H 3   ,H 4   ,H 5   ). 13C NMR (125MHz, DMSO): δ
164.2, 163.6, 148.9, 139.0, 136.0, 134.4, 131.1, 130.9, 130.1,
129.1, 128.8, 128.0, 127.1, 126.5, 125.6, 124.0, 121.1, 119.9.
Anal. Calcd. for C20H12Cl3NO3 (420.67): C, 57.10; H, 2.88;
N, 3.33. Found: C, 56.95; H, 2.82; N, 3.59.
2-(3-Bromophenylcarbamoyl)-4-chlorophenyl Benzoate (7).
White solid; yield 84%; mp 144–146◦C. IR (ATR): 3325 (NH
amide; m), 3079, 2930, 2852, 1716 (CO ester; s), 1671 (CO
amide; s), 1586, 1520, 1479, 1450, 1419, 1305, 1284, 1266,
1249, 1208, 1103, 1084, 1065, 1023, 893, 872, 783, 733, 702,
684,672. 1HNMR(500MHz,DMSO):δ 10.67(1H,bs,NH),
8.07 (2H, d, J = 7.8Hz, H2  ,H 6   ), 7.89 (1H, s, H2 ), 7.83
(1H, d, J = 2.5Hz, H3), 7.73–7.69 (2H, m, H5, H6), 7.58–
7.50 (3H, m, H3  ,H 4   ,H 5   ), 7.45 (1H, d, J = 7.4Hz, H6 ),
7.36 (1H, t, J = 7.7Hz, H5 ), 7.24 (1H, d, J = 5.2Hz, H4 ).
13C NMR (125MHz, DMSO): δ 164.3, 163.0, 147.0, 140.4,
134.4, 131.7, 130.9, 130.4, 130.0, 129.1, 128.6, 128.0,
127.1, 126.7, 125.7, 122.3, 121.6, 118.7. Anal. Calcd. for
C20H13BrClNO3 (430.68): C, 55.78; H, 3.04; N, 3.25. Found:
C, 55.49; H, 3.20; N, 3.48.
2-(3-Bromophenylcarbamoyl)-5-chlorophenyl Benzoate (8).
White solid; yield 73%; mp 153.5–156◦C. IR (ATR): 3279
(NH amide; m), 1739 (CO ester; s), 1647 (CO amide; s),
1599, 1585, 1541, 1476, 1452, 1407, 1320, 1254, 1241, 1190,
1075, 1050, 1020, 914, 894, 854, 781, 702, 659. 1HN M R
(500MHz, DMSO): δ 10.63 (1H, bs, NH), 8.08 (2H, d,
J = 7.5Hz, H2  ,H 6   ), 7.89 (1H, s, H2 ), 7.79 (1H, d,
J = 8.3Hz, H3), 7.73–7.68 (2H, m, H4, H6), 7.58–7.53 (3H,
m, H3  ,H 4   ,H 5   ), 7.45 (1H, d, J = 7.0Hz, H6 ), 7.36
(1H, t, J = 7.6Hz, H5 ), 7.23 (1H, d, J = 5.2Hz, H4 ). 13C
NMR(125MHz,DMSO):δ 164.1, 163.5, 148.9, 140.5, 135.8,
134.4, 130.9, 130.1, 129.1, 128.6, 128.0, 127.1, 126.6, 126.5,
124.0, 122.2, 121.6, 118.7. Anal. Calcd. for C20H13BrClNO3
(430.68): C, 55.78; H, 3.04; N, 3.25. Found: C, 55.87; H, 3.31;
N, 3.46.
2-(4-Bromophenylcarbamoyl)-4-chlorophenyl Benzoate (9).
White solid; yield 79%; mp 199–201◦C. IR (ATR): 3308 (NH
amide; m), 2932, 1739 (CO ester; s), 1668 (CO amide; s),
1597, 1541, 1487, 1449, 1403, 1314, 1258, 1246, 1197, 1099,
1053, 1023, 875, 833, 813, 706. 1H NMR (500MHz, DMSO):
δ 10.64 (1H, bs, NH), 8.06 (2H, d, J = 7.3Hz, H2  ,H 6   ),
7.82 (1H, d, J = 2.5Hz, H3), 7.73–7.68 (2H, m, H5, H6),
7.59–7.45 (7H, m, H2 ,H 3  ,H 5  ,H 6  ,H 3   ,H 4   ,H 5   ). 13C
NMR(125MHz,DMSO):δ 164.3, 162.8, 147.0, 138.3, 134.4,
131.8, 131.7, 131.3, 130.4, 130.0, 129.1, 129.0, 128.7, 125.6,
121.9, 115.7. Anal. Calcd. for C20H13BrClNO3 (430.68): C,
55.78; H, 3.04; N, 3.25. Found: C, 55.55; H, 3.01; N, 3.51.
2-(4-Bromophenylcarbamoyl)-5-chlorophenyl Benzoate (10).
White solid; yield 73%; mp 201–203◦C. IR (ATR): 3326 (NH
amide; m), 2929, 1745 (CO ester; s), 1651 (CO amide; s),
1601, 1587, 1531, 1487, 1450, 1397, 1260, 1241, 1189, 1176,
1073, 1051, 1020, 914, 893, 823, 810, 762, 703. 1HN M R
(500MHz, DMSO): δ 10.61 (1H, bs, NH), 8.07 (2H, d, J =
7.5Hz, H2  ,H 6   ), 7.78 (1H, d, J = 8.3Hz, H3), 7.73–7.67
(2H, m, H4, H6), 7.59–7.53 (5H, m, H2 ,H 6  ,H 3   ,H 4   ,
H5  ), 7.45 (2H, d, J = 8.8Hz, H3 ,H 5  ). 13CN M R
(125MHz,DMSO):δ 164.2,163.3,148.9,138.3,135.7,134.4,
131.7, 130.9, 130.0, 129.1, 128.7, 128.6, 126.5, 123.9, 121.8,
115.7. Anal. Calcd. for C20H13BrClNO3 (430.68): C, 55.78;
H, 3.04; N, 3.25. Found: C, 55.67; H, 2.93; N, 3.29.
4-Chloro-2-(3-ﬂuorophenylcarbamoyl)phenyl Benzoate (11).
White solid; yield 61%; mp 143–144.5◦C. IR (ATR): 3324
(NH amide; m), 2930, 2852, 1716 (CO ester; s), 1673 (CO
amide; s), 1601, 1531, 1485, 1452, 1437, 1316, 1268, 1208,
1176,1104,1086,1067,1022,965,858,784,733,704,681. 1H
NMR (500MHz, DMSO): δ 10.71 (1H, bs, NH), 8.07 (2H,
d, J = 7.9Hz, H2  ,H 6   ), 7.83 (1H, d, J = 2.5Hz, H3),
7.73–7.69 (2H, m, H5, H6), 7.57–7.46 (4H, m, H2 ,H 3   ,
H4  ,H 5   ), 7.40–7.29 (2H, m, H5 ,H 6  ), 6.92–6.86 (1H, m,
H4 ). 13C NMR (125MHz, DMSO): δ 164.3, 162.9, 163.1
and 161.2 (J = 241.5Hz), 147.0, 140.6 and 140.5 (J =
10.9Hz), 131.7, 131.2, 130.6 and 130.5 (J = 9.5Hz), 130.4,
130.0, 129.1, 128.6, 128.0, 127.1, 125.7, 115.7 and 115.7 (J =
2.5Hz), 110.6 and 110.5 (J = 21.0Hz), 106.8 and 106.6
(J = 26.0Hz). Anal. Calcd. for C20H13ClFNO3 (369.77): C,
64.96; H, 3.54; N, 3.79. Found: C, 64.80; H, 3.29; N, 3.58.
5-Chloro-2-(3-ﬂuorophenylcarbamoyl)phenyl Benzoate (12).
White solid; yield 78%; mp 149–151◦C. IR (ATR): 3295 (NH
amide; m), 3073, 2931, 1739 (CO ester; s), 1650 (CO amide;
s), 1596, 1550, 1489, 1450, 1423, 1324, 1256, 1241, 1196,
1171, 1149, 1075, 1053, 1022, 911, 845, 779, 704, 662. 1H
NMR (500MHz, DMSO): δ 10.68 (1H, bs, NH), 8.08 (2H, d,
J = 7.9Hz, H2  ,H 6   ), 7.79 (1H, d, J = 8.3Hz, H3), 7.73–
7.68 (2H, m, H4, H6), 7.58–7.51 (4H, m, H2 ,H 3   ,H 4   ,The Scientiﬁc World Journal 5
H5  ), 7.39–7.27 (2H, m, H5 ,H 6  ), 6.90–6.85 (1H, m, H4 ).
13CNMR(125MHz,DMSO):δ 164.2,163.5,163.1and161.2
(J = 241.4Hz), 148.9, 140.7 and 140.6 (J = 11.0Hz), 135.8,
134.4, 130.9, 130.6 and 130.5 (J = 9.4Hz), 130.1, 129.1,
128.6, 128.5, 126.5, 124.0, 115.7 and 115.6 (J = 2.6Hz),
110.5 and 110.4 (J = 21.1Hz), 106.7 and 106.5 (J =
26.1Hz). Anal. Calcd. for C20H13ClFNO3 (369.77): C, 64.96;
H, 3.54; N, 3.79. Found: C, 64.90; H, 3.24; N, 3.99.
4-Chloro-2-(4-ﬂuorophenylcarbamoyl)phenyl Benzoate (13).
White solid; yield 88%; mp 149–151◦C. IR (ATR): 3318 (NH
amide; m), 3076, 2929, 2852, 1715 (CO ester; s), 1665 (CO
amide; s), 1622, 1571, 1527, 1505, 1479, 1450, 1406, 1310,
1275, 1250, 1207, 1177, 1151, 1098, 1086, 1064, 1023, 892,
822, 778, 733, 697. 1H NMR (500MHz, DMSO): δ 10.56
( 1 H ,b s ,N H ) ,8 . 0 7( 2 H ,d ,J = 7.2Hz, H2  ,H 6   ), 7.81 (1H,
d, J = 2.6Hz, H3), 7.73–7.68 (2H, m, H5, H6), 7.63–7.59
(2H, m, H2 ,H 6  ), 7.55 (1H, t, J = 7.8Hz, H4  ), 7.51–
7.48 (2H, m, H3  ,H 5   ), 7.14–7.09 (2H, m, H3 ,H 5  ). 13C
NMR (125MHz, DMSO): δ 164.3, 162.6, 159.5 and 157.5
(J = 240.5Hz), 147.0, 135.2 and 135.2 (J = 2.6Hz), 134.3,
131.5, 130.4, 130.0, 129.1, 128.7, 128.0, 127.1, 125.6, 121.8
and 121.8 (J = 7.9Hz), 115.5 and 115.4 (J = 22.2Hz).
Anal. Calcd. for C20H13ClFNO3 (369.77): C, 64.96; H, 3.54;
N, 3.79. Found: C, 65.15; H, 3.47; N, 3.70.
5-Chloro-2-(4-ﬂuorophenylcarbamoyl)phenyl Benzoate (14).
White solid; yield 84%; mp 142–144◦C. IR (ATR): 3295 (NH
amide; m), 2930, 2852, 1739 (CO ester; s), 1647 (CO amide;
s), 1601, 1547, 1505, 1452, 1411, 1317, 1258, 1245, 1194,
1177, 1155, 1072, 1054, 1023, 893, 835, 826, 706. 1HN M R
(500MHz, DMSO): δ 10.52 (1H, bs, NH), 8.07 (2H, d, J =
7.9Hz, H2  ,H 6   ), 7.78 (1H, d, J = 8.3Hz, H3), 7.73–7.66
(2H, m, H4, H6), 7.63–7.59 (2H, m, H2 ,H 6  ), 7.57–7.53
(3H, m, H3  ,H 4   ,H 5   ), 7.13–7.08 (2H, m, H3 ,H 5  ). 13C
NMR (125MHz, DMSO): δ 164.2, 163.1, 159.4 and 157.5
(J = 240.5Hz), 148.9, 135.6, 135.3 and 135.3 (J = 2.5Hz),
134.4, 130.9, 130.0, 129.1, 128.6, 128.0, 126.4, 123.9, 121.8
and 121.7 (J = 7.9Hz), 115.5 and 115.3 (J = 22.3Hz).
Anal. Calcd. for C20H13ClFNO3 (369.77): C, 64.96; H, 3.54;
N, 3.79. Found: C, 64.74; H, 3.61; N, 3.94.
4-Chloro-2-(4-(triﬂuoromethyl)phenylcarbamoyl)phenylBen-
zoate (15). White solid; yield 44%; mp 179.5–181.5◦C. IR
(ATR): 3310 (NH amide; m), 1715 (CO ester; s), 1672 (CO
amide; s), 1601, 1526, 1476, 1452, 1407, 1317, 1278, 1253,
1207, 1168, 1110, 1086, 1063, 1015, 891, 867, 844, 820, 775,
703. 1HNMR(500MHz,DMSO):δ 10.87(1H,bs,NH),8.06
(2H, d, J = 7.8Hz, H2  ,H 6   ), 7.86 (1H, d, J = 2.6Hz,
H3), 7.82 (2H, d, J = 8.5Hz, H2 ,H 6  ), 7.75–7.68 (3H,
m, H5, H6), 7.65 (2H, d, J = 8.6Hz, H3 ,H 5  ), 7.57–7.51
(3H, m, H3  ,H 4   ,H 5   ). 13C NMR (125MHz, DMSO): δ
164.3, 163.2, 147.0, 142.5, 134.4, 131.9, 131.1, 130.4, 130.0,
129.2, 129.1, 128.6, 126.8 (q, J = 30.5Hz), 126.2 (d, J =
3.7Hz), 125.7, 124.4 (q, J = 271.4Hz), 119.9. Anal. Calcd.
for C21H13ClF3NO3 (419.78): C, 60.08; H, 3.12; N, 3.34.
Found: C, 60.31; H, 2.87; N, 3.09.
5-Chloro-2-(4-(triﬂuoromethyl)phenylcarbamoyl)phenylBen-
zoate (16). White solid; yield 80%; mp 177.5–179.5◦C. IR
(ATR): 3325 (NH amide; m), 2927, 1746 (CO ester; s), 1654
(CO amide; s), 1598, 1534, 1481, 1450, 1408, 1323, 1243,
1192, 1160, 1104, 1067, 1048, 1020, 916, 894, 845, 825, 763,
702. 1HNMR(500MHz,DMSO):δ 10.84(1H,bs,NH),8.07
(2H, d, J = 7.2Hz, H2  ,H 6   ), 7.83–7.79 (3H, m, H3, H2 ,
H6 ), 7.71–7.67 (2H, m, H4, H6), 7.64 (2H, d, J = 8.1Hz,
H3 ,H 5  ), 7.60–7.54 (3H, m, H3  ,H 4   ,H 5   ). 13CN M R
(125MHz,DMSO):δ 164.2,163.7,149.0,142.5,135.9,134.4,
131.0, 130.0, 129.1, 128.5, 128.5, 126.5, 126.2 (q, J = 3.8Hz),
124.6 (q, J = 285.3Hz), 124.0, 123.9 (q, J = 32.0Hz), 119.8.
Anal. Calcd. for C21H13ClF3NO3 (419.78): C, 60.08; H, 3.12;
N, 3.34. Found: C, 60.22; H, 3.21; N, 3.43.
4-Chloro-2-(3-(triﬂuoromethyl)phenylcarbamoyl)phenylBen-
zoate (17). White solid; yield 72%; mp 159.5–162◦C. IR
(ATR): 3314 (NH amide; m), 2931, 2853, 1714 (CO ester;
s), 1670 (CO amide; s), 1597, 1540, 1443, 1326, 1274, 1206,
1166, 1119, 1097, 1084, 1064, 1023, 906, 800, 735, 695. 1H
NMR (500MHz, DMSO): δ 10.83 (1H, bs, NH), 8.07 (2H, d,
J = 7.2Hz, H2  ,H 6   ), 8.00 (1H, s, H2 ), 7.87 (1H, d, J =
2.6Hz, H3), 7.74–7.68 (2H, m, H5, H6), 7.56–7.50 (4H, m,
H6 ,H 3   ,H 4   ,H 5   ), 7.46–7.35 (2H, m, H4 ,H 5  ). 13C
NMR(125MHz,DMSO):δ 164.3, 163.1, 147.0, 139.6, 134.4,
131.8, 131.1, 130.4, 130.2, 130.0, 129.6 (q, J = 31.7Hz),
129.1, 128.6, 128.0, 125.7, 124.2 (q, J = 272.6Hz), 123.6,
120.4 (q, J = 3.6Hz), 116.1 (q, J = 3.9Hz). Anal. Calcd. for
C21H13ClF3NO3 (419.78): C, 60.08; H, 3.12; N, 3.34. Found:
C, 60.19; H, 3.35; N, 2.99.
4-Bromo-2-(4-(triﬂuoromethyl)phenylcarbamoyl)phenyl Ben-
zoate (18). White solid; yield 79%; mp 177.5–180◦C. IR
(ATR): 3309 (NH amide; m), 1714 (CO ester; s), 1672 (CO
amide; s), 1600, 1526, 1474, 1451, 1406, 1317, 1280, 1252,
1208, 1169, 1111, 1086, 1064, 1041, 862, 843, 818, 720, 703.
1H NMR (500MHz, DMSO): δ 10.87 (1H, bs, NH), 8.06
(2H, d, J = 7.2Hz, H2  ,H 6   ), 7.97 (1H, d, J = 2.4Hz,
H3), 7.85 (1H, dd, J = 2.5Hz, J = 8.6Hz, H5), 7.82 (2H, d,
J = 8.5Hz, H2 ,H 6  ), 7.70 (1H, t, J = 7.5Hz, H4  ), 7.65
(2H, d, J = 8.2Hz, H3 ,H 5  ), 7.54 (2H, t, J = 7.9Hz, H3  ,
H5  ), 7.45 (1H, d, J = 8.6Hz, H6). 13C NMR (125MHz,
DMSO): δ 164.2, 163.1, 147.5, 142.5, 134.8, 134.4, 132.0,
131.4, 130.0, 129.1, 128.6, 126.7 (q, J = 37.3Hz), 126.2 (d,
J = 3.7Hz), 126.0, 124.4 (q, J = 271.5Hz), 119.9, 118.5.
Anal. Calcd. for C21H13BrF3NO3 (464.23): C, 54.33; H, 2.82;
N, 3.02. Found: C, 54.16; H, 3.03; N, 3.35.
3.2. Biology
3.2.1. Antibacterial Evaluation. Salicylanilide benzoates were
assayed for their in vitro antibacterial activity towards eight
strains. Benzoic acid expressed no activity up to 500μmol/L.
Table 1 summarizes the results with respect to structure of
the esters.
Almost all benzoates exhibited a very good activity
against both strains of S. aureus with MIC from 0.98 to
31.25μmol/L (10 being an exception). Importantly, MIC for6 The Scientiﬁc World Journal
Table 2: In vitro antifungal activity of salicylanilide benzoates.
MIC/IC80 [μmol/L]
Candida albicans Candida krusei Trichosporon asahii Absidia corymbifera Trichophyton mentagrophytes
24h 48h 24h 48h 24h 48h 24h 48h 72h 120h
(1) 250 >500 125 >500 >500 >500 500 >500 250 >500
(6) 125 >125 15.62 >125 3.9 15.62 125 125 31.25 31.25
(8) >250 >250 >250 >250 >250 >250 250 >250 >250 >250
(9) >125 >125 >125 >125 >125 >125 125 125 62.5 62.5
(13) >125 >125 >125 >125 >125 >125 62.5 >125 125 125
(18) >125 >125 >125 >125 >125 >125 >125 >125 62.5 125
BA >500 >500 >500 >500 >500 >500 >500 >500 >500 >500
FLU 1.00 2.00 >50.0 >50.0 4.00 9.00 >50.0 >50.0 17.0 26.0
FLU: ﬂuconazole; BA: benzoic acid. The best MIC value for each strain is bolded.
drug-sensitive and MRSA strain did not diﬀer practically,
whichindicatesnonecrossresistance.AlsoS.epidermidiswas
aﬀected by the majority of evaluated compounds (without
3) at only slightly higher concentrations from 1.95μmol/L.
Enterococcus was the most insensitive Gram-positive strain,
although it was inhibited by four esters (5, 6, 15, 18)a t
1.95μmol/L; six esters (2, 3, 4, 10, 14, 16) were inactive
at 125μmol/L. Molecules 6 and 15 were found having the
highest in vitro inhibitory potency. MIC values against three
Staphylococci support the hypothesis that these derivatives
act as bactericidal agents.
SomesalicylanilidebenzoatesMICvaluesarecomparable
to benzylpenicillin towards S. aureus, but almost all esters
are favorable against MRSA and S. epidermidis. The situation
for Enterococcus is quite more complex; some benzoates
exhibited better MIC value (5, 6, 15, 18), some comparable
after24h(7,8,12,17)andotherworsethanbenzylpenicillin.
When concentrated on the structure-activity relation-
ships, the position of the substituents on the salicylic ring is
ambiguous—in some cases are superior 4-chloro derivatives
(e.g., 1 versus 2, 9 versus 10, 15 versus 16), in other 5-chloro
ones (5 versus 6 or 7 versus 8). For the substitution of the
aniline ring, 3,4-dichloro (5, 6) and CF3-( 15–18)m o i e t i e s
improved the antibacterial activity the most signiﬁcantly.
In general, it seems that 3-substituted anilines produced a
higher antibacterial activity than 4-substituted anilines.
Gram-negative species (E. coli, two strains of Klebsiella
pneumoniae, P. aeruginosa) were almost completely resistant
to benzoates up to 125μmol/L at the testing conditions with
onenotableexception;P. aeruginosa wasinhibitedby 1atlow
concentration of 3.9/7.81μmol/L.
3.2.2. Antifungal Evaluation. Synthesized esters were tested
for their in vitro activity against eight human pathogenic
fungi. MIC values are presented in Table 2. Benzoic acid
alone was completely inactive at the concentration of
500μmol/L at both neutral and slightly acidic (pH ∼ 5)
environment.
Unforeseen, in contrast to the antibacterial activity, sali-
cylanilide benzoates expressed only mild antifungal potency.
Fromeight strains, C. tropicalis,C.glabrata,andA.fumigatus
showed a complete insensitivity to all tested derivatives at
the value of 125μmol/L. When concentrated on the esters,
benzoates 2 and 11 did not aﬀect the growth of any fungal
species at the concentration of 500μmol/L and lower, deriva-
tives 12, 14, and 17 up to 250μmol/L and 3, 4, 5, 7, 10, 15,
16 expressed activity levels >125μmol/L. Only six derivatives
(1, 6, 8, 9, 13, 18) displayed certain in vitro eﬃcacy. The
most active compound was assayed trichlorinated ester 6
(MIC ≥ 3.9μmol/L), which surpassed standard ﬂuconazole
against C. krusei. In general, Candida is more resistant to
salicylanilide esters than moulds and moreover, it seems that
the mechanism of the action is only fungistatic. On the other
side, the growth of T. mentagrophytes was aﬀected by the
highest number of the derivatives; based on the MIC values,
activity against ﬁlamentous fungi is probably fungicidal.
Because pH eﬀect on the eﬃciency of benzoic acid
derivatives (generally of weak organic acids) was described
(e.g., [16]), we measured MIC values of the esters 6 and
15 not only at approximately neutral environment, but
additionally at slightly acidic pH (∼5; without buﬀering of
the testing medium). Unfortunately, the change of pH did
not result in the improvement of activity, even it led to a bit
worse values.
Although we expected that the introduction of benzoyl
fragment into salicylanilide molecules resulted in the signif-
icantly increased antifungal potency, this modiﬁcation failed
in this point.
4. Conclusion
In sum, we have designed and synthesized new esters of
halogenated salicylanilides with benzoic acid. This series of
compounds was evaluated to be a new group with promising
in vitro antibacterial (against Gram-positive strains) activity.
Unfortunately these derivatives disappointed expectation
about them as potential antifungal agents.
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